Kolexia
Palussiere Jean
Radio-diagnostic
Institut Bergonié
Bordeaux, France
124 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Métastase tumorale Tumeurs du poumon Tumeurs osseuses Carcinomes Carcinome pulmonaire non à petites cellules Tumeurs du sein Récidive tumorale locale Sarcomes Tumeurs du foie

Industries

Boston Scientific
10 collaboration(s)
Dernière en 2023
Bracco Imaging
2 collaboration(s)
Dernière en 2022
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.
Molecular cancer   19 février 2024
1920MO Regomune: A phase II study of regorafenib + avelumab in solid tumors - Results of the advanced or metastatic gastrointestinal stromal tumors (mGIST) cohort
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades.
Cancers   28 août 2023
Y a-t-il une place pour la thermoablation dans le traitement du cancer du sein ? Pour quelles patientes ?
Congrès SIFEM 2023   01 juin 2023
Radiofrequency ablation of lung metastases of colorectal cancer: could early radiomics analysis of the ablation zone help detect local tumor progression?
The British journal of radiology   17 avril 2023
Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency Ablation.
Cancers   22 novembre 2022
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study.
Journal of hematology & oncology   27 octobre 2022
1494P Regomune - a phase II study of regorafenib + avelumab in solid tumors: Results of the soft tissue sarcoma (STS) cohort
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the oesophageal or gastric carcinoma (OGC) cohort.
2022 ASCO Annual Meeting I   02 juin 2022
REGOMUNE: Phase II study of regorafenib plus avelumab in solid tumors—Results of the gastroenteropancreatic neuroendocrine carcinomas (GEP-NEC) cohort.
2022 ASCO Annual Meeting I   02 juin 2022